Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • ABOUT THE IPILOGUE
    • BLOG
      • Announcements
      • Artificial Intelligence
      • Copyright
      • Innovation
      • IP Innovation Clinic
      • IP Intensive
      • Patents
      • Privacy
      • Technology
      • Trademarks
    • IPILOGUE TEAM
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
    • WRITE FOR US
  • IP INNOVATION CLINIC
    • ABOUT
    • CHATBOT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • THE IP LUNCH CLUB
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • UPCOMING EVENTS
    • PAST EVENTS
  • CONTESTS & COMPETITIONS
    • 2021 Oxford International Intellectual Property Law Moot
    • IP WRITING CHALLENGE
    Home
    >
    myriad

    Tag: myriad

    August 14, 2013in Canada, Infringement, IP, Patentability, Patents, Pharmaceutical Drugs, Tech Transfer, US, US-Canada Relations0by Editor
    1032

    SickKids in Court - Are Public-Private Research Collaborations a Hindrance or a Driver of the Innovative Process?

    A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…

    Read more
    June 25, 2013in Jurisdiction, Patentability, Patents, US0by Editor
    1310

    Isolated Genes Are None Of Your Business! – SCOTUS Decides Myriad

    On June 13, 2013, the U.S. Supreme Court rendered a decision which ruled against the patenting of isolated DNA sequences in their natural form in the now infamous case involving Myriad Genetics, Inc.…

    Read more
    September 14, 2012in Access to Medicines, Patentability, Patents, US0by Editor
    1382

    U.S. Court of Appeals Stands Tall on the Subject of Gene Patents in the Wake of the Mayo v Prometheus Ruling

    The United States Court of Appeals for the Federal Circuit, in the case Association for Molecular Pathology (AMP) and ACLU v. USPTO and Myriad Genetics (Myriad), held in August that…

    Read more
    July 2, 2012in Commercialization, Competition, Innovation, IP, Patentability, Patents, US0by Editor
    699

    The Patentability of Gene Sequences: Myriad Genetics’ Day in the United States Supreme Court

    In late March, The United States Supreme Court ordered the U.S Court of Appeal for the Federal Circuit to reconsider Myriad Genetics’ existing patent on two genes associated with a…

    Read more
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736